Atlas Trials

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

Clinical trial NCT05669092 · UNKNOWN

Trial details

NCT number
NCT05669092
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
ToripalimabRadiation
Start date
2022-11-01
Primary completion
2025-12-31
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.